To the extent statements contained in this news release are not descriptions of historical facts regarding Emerald Health Pharmaceuticals Inc. they should be considered “forward-looking statements,” as described in the private securities litigat...
Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has concluded the merger transaction with Emerald Health Therapeutics ("Emerald"). Both
| aldevron | alerchek | alere | alexis | alfa | All Foils Incorporated | allele biotech | allelebiotech | allen-bradley | Allied K&R Broom & Bristle | allstar scientific | alnylam pharmaceuticals | alomone labs | alpco | alpha diagnoestic international | alpha diagnostics | alpha innotech | ...
Emerald invests in Life Sciences companies that embrace strategic innovation, driving the development of new therapies, technologies, and healthcare solutions to create value and foster long-term growth. Biotechnology Healthcare Pharmaceuticals Medical Equipment Medical Services Innovative companies ar...
Though he works as a sell-side analyst on Wall Street, Corey Davis of Darien is also passionate about focusing on specialty pharmaceuticals that treat central nervous system disorders. By focusing on both the financial and health care vantage points, Corey Davis of Darien is able to provide the...
"Our laboratory has ongoing research with the USDA Animal Plant Health Inspection Service into remote-reporting, Internet-based technologies, and we will be working to couple this research with our ash-borer detection technique so that activity of the pest can be reported and assessed immediately by...
Other factors could include marketing and distribution of these pharmaceuticals. These practices although extremely important, represent a very traditional view of drug companies. In other words drug companies primary business is to develop, manufacture, and distribute drugs. Starting in the mid 1980s ...